{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "esgPopulated": false, "market": "tw_market", "longName": "Andros Pharmaceuticals Co.,Ltd", "marketState": "POSTPOST", "regularMarketPrice": 34.25, "messageBoardId": "finmb_552152255", "exchange": "TWO", "shortName": "Andros", "exchangeTimezoneShortName": "CST", "exchangeTimezoneName": "Asia/Taipei", "regularMarketChangePercent": -2.1428573, "gmtOffSetMilliseconds": 28800000, "fiftyTwoWeekLowChange": 8.950001, "fiftyTwoWeekLowChangePercent": 0.35375497, "fiftyTwoWeekRange": "25.3 - 46.3", "fiftyTwoWeekHighChange": -12.049999, "fiftyTwoWeekHighChangePercent": -0.26025918, "fiftyTwoWeekLow": 25.3, "fiftyTwoWeekHigh": 46.3, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.3, "firstTradeDateMilliseconds": 1673485200000, "priceHint": 2, "regularMarketChange": -0.75, "regularMarketTime": 1684133986, "regularMarketDayHigh": 35.7, "regularMarketDayRange": "33.75 - 35.7", "regularMarketDayLow": 33.75, "regularMarketVolume": 134066, "regularMarketPreviousClose": 35.0, "bid": 33.85, "ask": 34.3, "fullExchangeName": "Taipei Exchange", "regularMarketOpen": 35.0, "averageDailyVolume3Month": 370062, "averageDailyVolume10Day": 143223, "sharesOutstanding": 34772000, "fiftyDayAverage": 37.086, "fiftyDayAverageChange": -2.8359985, "fiftyDayAverageChangePercent": -0.07647087, "twoHundredDayAverage": 35.425335, "twoHundredDayAverageChange": -1.1753349, "twoHundredDayAverageChangePercent": -0.033177808, "marketCap": 1194311168, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "symbol": "6917.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 22, Shengyi Road", "address2": "6th Floor Section 2", "city": "Zhubei", "zip": "30261", "country": "Taiwan", "phone": "886 3 658 1866", "fax": "886 3 658 1966", "website": "https://www.andros.com.tw", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Andros Pharmaceuticals Co.,Ltd, a biopharmaceutical company, engages in developing novel drug delivery platform technologies. The company develops APC101, a fast-drying, film-forming, and meter-dosed spray, which is in Phase IIa clinical trial to treat pain associated with post-herpetic neuralgia; APC201, a novel dosage form of topical anesthetic that is in Phase I/II clinical trial for treatment of Osteoarthritis; and siRNA, an anti-sense oligonucleotide and DNA candidate. Its preclinical phase products are APC310 and APC501 for anesthesia to intravenous catheter placement and venipuncture; and APC401, a special emulsified solution for anesthesia of post-surgery pain. The company offers LALP cream for dermal analgesic applications; iMinos solution for Alopecia Androgenetica; and T4 endonuclease V. Andros Pharmaceuticals Co.,Ltd was founded in 2008 and is based in Zhubei, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Ming-Wen  Lee", "title": "Mang.ial Officer & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}